See the latest PIR International News, Articles and Network Updates.
2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study
PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. [...]
2025/26 EU/UK Biotech & Life Sciences C-Suite Remuneration & Diversity Study
PIR International’s EU/UK Biotech & Life Sciences C-Suite Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and boards with the insights they need to guide company governance, business strategy and strive for excellence. This strictly [...]
Anja Harmeier – BioLeader Interview
Chief Executive Officer, Rewind Therapeutics (July 2024) Anja Harmeier is an experienced drug developer, scientist and entrepreneur in neuroscience and rare diseases. She brings extensive R&D and operational capabilities complemented by a strong track record in company development and venture [...]
Ian Nicholson – BioLeader Interview
Operating Partner, Advent Life Sciences LLP (April 2024) Ian has over thirty-five years of international experience in management and transactions within the life sciences sector. He is currently Chairman of Bioventix plc, a Board Trustee of LifeArc, a leading UK [...]